|
USRE46117E1
(en)
|
1999-12-22 |
2016-08-23 |
Teva Pharmaceuticals International Gmbh |
Modulators of dopamine neurotransmission
|
|
SE9904724D0
(sv)
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission I
|
|
SE9904723D0
(sv)
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission II
|
|
JP2004523530A
(ja)
|
2001-01-23 |
2004-08-05 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニストとしてのピペラジンおよびピペリジン誘導体
|
|
CA2433025A1
(en)
|
2001-01-23 |
2002-08-01 |
Chaoyu Xie |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
|
EP1358163A1
(en)
|
2001-01-23 |
2003-11-05 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
EP1363898A4
(en)
|
2001-03-02 |
2004-12-08 |
Bristol Myers Squibb Co |
COMPOUNDS SUITABLE AS MODULATORS OF MELANOCORTIN RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
|
US6911447B2
(en)
|
2001-04-25 |
2005-06-28 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US7115607B2
(en)
*
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
US6977264B2
(en)
*
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US7456184B2
(en)
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
|
US7354923B2
(en)
|
2001-08-10 |
2008-04-08 |
Palatin Technologies, Inc. |
Piperazine melanocortin-specific compounds
|
|
WO2003013571A1
(en)
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
|
UA81749C2
(uk)
*
|
2001-10-04 |
2008-02-11 |
Х. Луннбек А/С |
Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
|
|
EP1469851B1
(en)
|
2002-01-23 |
2006-10-11 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
US7026335B2
(en)
|
2002-04-30 |
2006-04-11 |
The Procter & Gamble Co. |
Melanocortin receptor ligands
|
|
JP2005534632A
(ja)
*
|
2002-05-10 |
2005-11-17 |
ニューロクライン バイオサイエンセズ， インコーポレイテッド |
メラノコルチンレセプターリガンドとしての置換ピペラジン
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
US7414057B2
(en)
|
2002-09-11 |
2008-08-19 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
|
US7132539B2
(en)
*
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
WO2004081643A1
(en)
*
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US7160886B2
(en)
|
2003-03-03 |
2007-01-09 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
|
US20060178403A1
(en)
*
|
2003-03-07 |
2006-08-10 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
|
CA2517291C
(en)
*
|
2003-03-19 |
2012-05-08 |
Exelixis, Inc. |
Ortho-substituted aryl and heteroaryl tie-2 modulators and methods of use
|
|
EP1460069A1
(en)
*
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
|
EP1468999A1
(en)
*
|
2003-03-20 |
2004-10-20 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
ATE474577T1
(de)
|
2003-03-26 |
2010-08-15 |
Merck Sharp & Dohme |
Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
|
|
MXPA05013365A
(es)
*
|
2003-06-20 |
2006-04-05 |
Arena Pharm Inc |
Derivados de n-fenil-piperazina y metodos para profilaxis o tratamiento de enfermedades asociadas con el receptor 5ht2c.
|
|
WO2005028438A1
(ja)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
新規ピペリジン誘導体
|
|
US20050119252A1
(en)
*
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US20050192286A1
(en)
*
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
EP1538159A1
(en)
*
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
|
MY140489A
(en)
*
|
2003-12-26 |
2009-12-31 |
Eisai R&D Man Co Ltd |
1,2-di (cyclic) substituted benzene compounds
|
|
CN100526301C
(zh)
*
|
2003-12-26 |
2009-08-12 |
卫材R&D管理有限公司 |
1,2-二(环式基)取代苯化合物
|
|
US20060276465A1
(en)
*
|
2003-12-26 |
2006-12-07 |
Eisai R&D Management Co., Ltd. |
1,2-di(cyclic) substituted benzene compounds
|
|
US7410971B2
(en)
|
2003-12-26 |
2008-08-12 |
Eisai R&D Management Co., Ltd. |
1,2-di(cyclic)substituted benzene compounds
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
SE0401465D0
(sv)
|
2004-06-08 |
2004-06-08 |
Carlsson A Research Ab |
New substituted piperdines as modulators of dopamine neurotransmission
|
|
MXPA06013941A
(es)
|
2004-06-08 |
2007-12-10 |
Neurosearch Sweden Ab |
Fenilpiperidinas disustituidas, novedosas, como moduladores de la neurotransmision de dopamina y serotonina.
|
|
CA2569843A1
(en)
*
|
2004-06-08 |
2005-12-22 |
A. Carlsson Research Ab |
New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
|
|
RU2366654C2
(ru)
*
|
2004-06-08 |
2009-09-10 |
ЭнЭсЭйБи, ФИЛИАЛ АФ НЕУРОСЕРЧ СВИДЕН АБ, СВЕРИЙЕ |
Новые дизамещенные фенилпиперидины/пиперазины в качестве модуляторов допаминовой нейротрансмиссии
|
|
US7851629B2
(en)
|
2004-06-08 |
2010-12-14 |
Nsab, Filial Af Neurosearch Sweden Ab, Sverige |
Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
|
|
ES2659577T3
(es)
|
2004-10-13 |
2018-03-16 |
Teva Pharmaceuticals International Gmbh |
Proceso para la síntesis de 4-(3-metanosulfonilfenil)-1-N-propil-piperidina
|
|
TW200633721A
(en)
*
|
2004-12-14 |
2006-10-01 |
Shionogi & Co |
A pharmaceutical composition for treating constipation
|
|
US7910734B2
(en)
|
2004-12-20 |
2011-03-22 |
Eisai R&D Management Co., Ltd. |
Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine
|
|
EP1892241B1
(en)
|
2005-05-30 |
2016-03-30 |
Msd K.K. |
Novel piperidine derivative
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
MY144974A
(en)
*
|
2005-06-14 |
2011-11-30 |
Eisai R&D Man Co Ltd |
1,2-di(cyclic) substituted benzene derivatives
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDOLVERBINDUNG
|
|
US7875633B2
(en)
|
2005-08-24 |
2011-01-25 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
KR20080048502A
(ko)
|
2005-09-29 |
2008-06-02 |
머크 앤드 캄파니 인코포레이티드 |
멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
|
|
SE529246C2
(sv)
|
2005-10-13 |
2007-06-12 |
Neurosearch Sweden Ab |
Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
|
|
CA2625877A1
(en)
|
2005-10-18 |
2007-04-26 |
Merck & Co., Inc. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
RU2008119687A
(ru)
|
2005-10-21 |
2009-11-27 |
Новартис АГ (CH) |
Комбинации органических соединений
|
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
|
RU2428423C2
(ru)
|
2005-11-10 |
2011-09-10 |
Баниу Фармасьютикал Ко., Лтд. |
Азазамещенные спиропроизводные
|
|
US7601844B2
(en)
*
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
|
WO2007096186A1
(en)
*
|
2006-02-23 |
2007-08-30 |
Santhera Pharmaceuticals (Schweiz) Ag |
Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
NZ574028A
(en)
|
2006-07-05 |
2010-10-29 |
Fibrotech Therapeutics Pty Ltd |
Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis
|
|
AU2007300627B2
(en)
|
2006-09-22 |
2012-02-16 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
EP2072519A4
(en)
|
2006-09-28 |
2009-10-21 |
Banyu Pharma Co Ltd |
DIARYLKETIMINDERIVAT
|
|
AU2008233662B2
(en)
|
2007-04-02 |
2012-08-23 |
Msd K.K. |
Indoledione derivative
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2019100A1
(en)
*
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
EP2020405A1
(en)
*
|
2007-07-30 |
2009-02-04 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
AU2009220605A1
(en)
|
2008-03-06 |
2009-09-11 |
Msd K.K. |
Alkylaminopyridine derivative
|
|
CA2717384A1
(en)
|
2008-03-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
|
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
TWI433838B
(zh)
|
2008-06-25 |
2014-04-11 |
必治妥美雅史谷比公司 |
作為趨化因子受體活性調節劑之六氫吡啶衍生物
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
US20110124674A1
(en)
|
2008-07-30 |
2011-05-26 |
Hiroyuki Kishino |
5/5-or 5/6-membered condensed ring cycloalkylamine derivative
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010051206A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
UA99555C2
(en)
|
2008-11-12 |
2012-08-27 |
Элджи Лайф Саенсез Лтд. |
Melanocortin receptor agonists
|
|
JP5514831B2
(ja)
|
2008-11-17 |
2014-06-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病の治療のための置換二環式アミン
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
EP2947073B1
(en)
|
2009-10-22 |
2019-04-03 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
US8785634B2
(en)
|
2010-04-26 |
2014-07-22 |
Merck Sharp & Dohme Corp |
Spiropiperidine prolylcarboxypeptidase inhibitors
|
|
WO2011143057A1
(en)
|
2010-05-11 |
2011-11-17 |
Merck Sharp & Dohme Corp. |
Novel prolylcarboxypeptidase inhibitors
|
|
EP2579873A4
(en)
|
2010-06-11 |
2013-11-27 |
Merck Sharp & Dohme |
NOVEL PROLYLCARBOXYPEPTIDASE HEMMER
|
|
US8642622B2
(en)
|
2010-06-16 |
2014-02-04 |
Bristol-Myers Squibb Company |
Piperidinyl compound as a modulator of chemokine receptor activity
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
WO2012100342A1
(en)
|
2011-01-27 |
2012-08-02 |
Université de Montréal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
EP2787997A4
(en)
|
2011-12-08 |
2015-05-27 |
Ivax Int Gmbh |
HYDROBROMIDE SALT OF PRIDOPIDINE
|
|
MX352181B
(es)
|
2012-02-02 |
2017-11-13 |
Idorsia Pharmaceuticals Ltd |
Compuestos 4- (benzoimidazol-2-il) -tiazol y derivados aza relacionados.
|
|
BR112014024672A8
(pt)
|
2012-04-04 |
2018-04-03 |
Ivax Int Gmbh |
Composições farmacêuticas para terapia de combinação
|
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
EP2746259A1
(en)
|
2012-12-21 |
2014-06-25 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds
|
|
EP2746260A1
(en)
|
2012-12-21 |
2014-06-25 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds
|
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
抗糖尿病二環式化合物
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
PT3006454T
(pt)
|
2013-06-05 |
2021-01-29 |
Shanghai Lumosa Therapeutics Co Ltd |
Novos compostos possuindo atividades triplas de trombólise, antitrombótica e sequestrante de radicais, e suas síntese, nanoestrutura e utilização
|
|
PL3004138T3
(pl)
|
2013-06-05 |
2024-07-29 |
Bausch Health Ireland Limited |
Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
|
|
TR201807959T4
(tr)
|
2013-07-22 |
2018-06-21 |
Idorsia Pharmaceuticals Ltd |
1-(Piperazın-1-il)-2- ([1,2,4] triazol-1-il)-etanon türevleri.
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
AR099789A1
(es)
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
BR112017003745A2
(pt)
|
2014-08-29 |
2017-12-05 |
Tes Pharma S R L |
inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
AR103399A1
(es)
|
2015-01-15 |
2017-05-10 |
Actelion Pharmaceuticals Ltd |
Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
|
|
RS58349B1
(sr)
|
2015-01-15 |
2019-03-29 |
Idorsia Pharmaceuticals Ltd |
Hidroksialkil-piperazinski derivati kao modulatori cxcr3 receptora
|
|
CN105294554B
(zh)
*
|
2015-11-18 |
2017-11-07 |
乳源瑶族自治县大众药品贸易有限公司 |
苯基哌嗪衍生物及其使用方法和用途
|
|
CN105348204B
(zh)
*
|
2015-11-18 |
2018-09-14 |
乳源瑶族自治县大众药品贸易有限公司 |
1-杂环基-2-(杂芳基硫基)苯衍生物及其使用方法和用途
|
|
CN105461635B
(zh)
*
|
2015-11-18 |
2018-06-08 |
乳源瑶族自治县大众药品贸易有限公司 |
苯基哌嗪衍生物及其使用方法和用途
|
|
AU2017342083A1
(en)
|
2016-10-14 |
2019-04-11 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
EP3577103A1
(en)
|
2017-02-03 |
2019-12-11 |
Certa Therapeutics Pty Ltd. |
Anti-fibrotic compounds
|
|
EP3883930A1
(en)
|
2018-11-20 |
2021-09-29 |
Tes Pharma S.r.l. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
EP3821947A1
(en)
*
|
2019-11-13 |
2021-05-19 |
Libra Therapeutics, Inc. |
Heterocyclic trpml1 agonists
|
|
US12698266B2
(en)
*
|
2019-12-19 |
2026-08-04 |
Casma Therapeutics, Inc. |
TRPML modulators
|
|
AR129265A1
(es)
|
2022-05-12 |
2024-08-07 |
Syngenta Crop Protection Ag |
Compuestos de alcoxi-heteroaril-carboxamida o tioamida
|
|
WO2024033374A1
(en)
|
2022-08-11 |
2024-02-15 |
Syngenta Crop Protection Ag |
Novel arylcarboxamide or arylthioamide compounds
|
|
WO2024089216A1
(en)
|
2022-10-27 |
2024-05-02 |
Syngenta Crop Protection Ag |
Novel sulfur-containing heteroaryl carboxamide compounds
|
|
JP2026500298A
(ja)
|
2022-12-15 |
2026-01-06 |
シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト |
殺有害生物剤として有用である新規な二環式カルボキサミド化合物
|
|
AR131541A1
(es)
|
2023-01-07 |
2025-04-09 |
Syngenta Crop Protection Ag |
Compuestos de carboxamida novedosos
|
|
WO2025032129A1
(en)
|
2023-08-08 |
2025-02-13 |
Syngenta Crop Protection Ag |
Novel aminoindane and aminotetraline compounds
|
|
CN122228245A
(zh)
|
2023-11-14 |
2026-06-16 |
先正达农作物保护股份公司 |
新颖的羧酰胺化合物
|
|
WO2025109114A1
(en)
|
2023-11-24 |
2025-05-30 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
WO2025149637A1
(en)
|
2024-01-12 |
2025-07-17 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
PY2501648A
(es)
|
2024-01-12 |
2025-10-31 |
Syngenta Crop Protection Ag |
Nuevos compuestos de carboxamida
|
|
WO2026008750A1
(en)
|
2024-07-05 |
2026-01-08 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
WO2026119962A1
(en)
|
2024-12-04 |
2026-06-11 |
Syngenta Crop Protection Ag |
Novel phenyl carboxamide compounds
|
|
WO2026120028A1
(en)
|
2024-12-04 |
2026-06-11 |
Syngenta Crop Protection Ag |
Novel heteroaryl carboxamide compounds
|